Bio-Techne (TECH) Common Equity (2010 - 2026)
Bio-Techne (TECH) reported Common Equity of $2.11 billion for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 9.9% from $1.92 billion a year earlier and up 1.1% from the prior quarter.
Bio-Techne (TECH) Common Equity (2010 - 2026) Analysis & Trends
Dating back to fiscal Q4 2010, Bio-Techne's Common Equity record includes 65 quarters.
- Common Equity has a five-year compound annual growth rate of 6.1% (FY2021 to FY2026).
- By fiscal year, Common Equity came in at $1.92 billion in FY2025 (-7.3%), $2.07 billion in FY2024 (+5.2%), $1.97 billion in FY2023 (+15.6%) and $1.7 billion in FY2022 (+8.3%).
- The fiscal Q4 2026 figure ranks as the highest quarterly Common Equity since fiscal Q1 2025.
- Year over year, Common Equity gained in five of the last eight quarters, with growth averaging 1.0%.
- The high point for year-over-year Common Equity in five years was fiscal Q4 2023 (growth of 15.6%); the low point was fiscal Q1 2026 (a decline of 8.1%).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $2.09 billion (Q3 2026), $2.01 billion (Q2 2026) and $1.97 billion (Q1 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.42 Bn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 10.72 Bn |
| 10 | Bio-Techne | 11.32 Bn | 10.53 Bn | 211.39 Mn | 2.11 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.11 Bn |
| Mar 31, 2026 | 2.09 Bn |
| Dec 31, 2025 | 2.01 Bn |
| Sep 30, 2025 | 1.97 Bn |
| Jun 30, 2025 | 1.92 Bn |
| Mar 31, 2025 | 2.02 Bn |
| Dec 31, 2024 | 2.08 Bn |
| Sep 30, 2024 | 2.14 Bn |
| Jun 30, 2024 | 2.07 Bn |
| Mar 31, 2024 | 2.01 Bn |
| Dec 31, 2023 | 1.96 Bn |
| Sep 30, 2023 | 2.00 Bn |
| Jun 30, 2023 | 1.97 Bn |
| Mar 31, 2023 | 1.89 Bn |
| Dec 31, 2022 | 1.83 Bn |
| Sep 30, 2022 | 1.75 Bn |
| Jun 30, 2022 | 1.70 Bn |
| Mar 31, 2022 | 1.71 Bn |
| Dec 31, 2021 | 1.70 Bn |
| Sep 30, 2021 | 1.65 Bn |
Bio-Techne Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=TECH&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "TECH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=TECH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();